No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹148.5Prev. Close
₹147.22Turnover(Lac.)
₹1,136.19Day's High
₹150.1Day's Low
₹145.652 Week's High
₹149.952 Week's Low
₹68.72Book Value
₹156.02Face Value
₹10Mkt Cap (₹ Cr.)
1,218.87P/E
26.85EPS
5.48Divi. Yield
025 Aug 2025
12:00 AM
AGM
Announcement Date: 25 Aug, 2025
25 Aug 2025
12:00 AM
BookCloser
28 Jan 2026
12:00 AM
Board Meeting
Agenda : Audited Result
20 Jan 2025
12:00 AM
EGM
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 142.84 | 67.21 | 59.81 | 59.81 |
Preference Capital | 14.2 | 14.2 | 0 | 0 |
Reserves | 1,021.24 | 730.94 | 615.54 | 572.75 |
Net Worth | 1,178.28 | 812.35 | 675.35 | 632.56 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 856.57 | 751.83 | 731.29 | 693.71 |
yoy growth (%) | 13.93 | 2.8 | 5.41 | 8.6 |
Raw materials | -424.99 | -378.84 | -375.06 | -395.81 |
As % of sales | 49.61 | 50.38 | 51.28 | 57.05 |
Employee costs | -104.16 | -100.37 | -89.3 | -71.61 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 16.11 | -19.56 | 30.51 | -50.85 |
Depreciation | -87.29 | -90.05 | -86.61 | -88.25 |
Tax paid | -20.51 | -1.22 | -10.95 | 16.46 |
Working capital | 24.4 | 224.01 | -12.39 | -206.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 13.93 | 2.8 | 5.41 | 8.6 |
Op profit growth | 27.14 | 11.71 | 20.97 | -3.11 |
EBIT growth | 32.31 | 49.44 | 56.9 | -0.94 |
Net profit growth | -78.84 | -217.94 | -144.36 | -32.51 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 561.71 | 1,709.15 | 1,207.31 | 1,038.73 | 891.34 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 561.71 | 1,709.15 | 1,207.31 | 1,038.73 | 891.34 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 304.59 | 479.35 | 33.5 | 43.5 | 22.7 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,764.2 | 96.97 | 4,23,194.7 | 705.44 | 0.91 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,395.5 | 66.02 | 1,69,849.45 | 598 | 0.47 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,418.9 | 66.98 | 1,49,586.12 | 577 | 0.14 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,306.5 | 23.5 | 1,09,054.46 | 90.6 | 0.61 | 4,266.4 | 377.55 |
Cipla Ltd CIPLA | 1,346.1 | 23.73 | 1,08,703.05 | 616.88 | 1.19 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / M D / Promoter
N R Munjal
ED / Joint MD / Promoter
Himanshu Jain
Executive Director
Rishav Mehta
Executive Director
Sahil Munjal
Independent Non Executive Women Director
Neerja Chathley
Independent Non Exe. Director
Rajinder Kumar Gupta
Independent Non Exe. Director
SUBODH GUPTA
Independent Non Exe. Director
Prabhat Khurana
VP / Company Secretary / Compliance Officer
Pradeep Verma
SCO 850 Shivalik Enclave,
NAC Manimajra,
Chandigarh - 160101
Tel: 91-0172-5061850/2730920
Website: http://www.indswiftlabs.com
Email: investor@indswiftlabs.com, info@indswiftlabs.com
205/208,
Anarkali Market, Jhandewalan Extn,
New Delhi - 110055
Tel: 011 - 42541234 / 235
Website: www.alankit.com
Email: rta@alankit.com
Summary
Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, Punjab, India. The Company is one of the leading manufacturers of APIs catering to global and domestic formu...
Read More
Reports by Ind-Swift Laboratories Ltd
What is the Ind-Swift Laboratories Ltd share price today?
What is the Market Cap of Ind-Swift Laboratories Ltd?
What is the PE and PB ratio of Ind-Swift Laboratories Ltd?
What is the 52 Week High and Low of Ind-Swift Laboratories Ltd?
What is the CAGR of Ind-Swift Laboratories Ltd?
What is the shareholding pattern of Ind-Swift Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
